Log In
Print this Print this


Also known as: dronabinol

  Manage Alerts
Collapse Summary General Information
Company Abbott Laboratories
DescriptionSynthetic delta-9-tetrahydrocannabinol
Molecular Target Cannabinoid receptors
Mechanism of ActionCannabinoid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationEmesis
Indication DetailsTreat chemotherapy-induced nausea and vomiting (CINV)
Regulatory Designation
PartnerAbbVie Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today